Article
Glaucoma drugs may pose risk to ocular surface
Author(s):
Orlando-Ophthalmologists should be aware of the risks to the ocular surface associated with long-term use of glaucoma medications, according to Robert J. Noecker, MD, MBA, who also spoke at the Cornea Health symposium during the American Academy of Ophthalmology annual meeting.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
